Professional societies have released an update to the "core competence" required of physicians wanting to perform percutaneous coronary interventions. In it, average annual volumes are lower, while patient-centered care, procedure appropriateness, and awareness of personal stats have moved to the forefront.
Speaking at the 2013 AATS meeting, Cheney describes his LVAD procedure the toughest of all his heart surgeries, while his transplant was a walk in the park. He and his cardiologist, Dr Jonathan Reiner, are coauthoring a book about Cheney's four-decade-long CVD odyssey.
One of the Lancet papers reviews the successes, failures, and ongoing challenges in beating back the "global tobacco epidemic," including a report from FDA scientists touting the impact of the 2009 Tobacco Control Act in the US.
It's never been clear whether the telltale metabolic signs at hospitalization tell the same prognostic story as in the outpatient setting. Certainly it wasn't known whether they had their own story to tell.
Salaries for US cardiologists climbed in 2012, making them the second-highest paid specialty, according to the 2013 Medscape Physician Compensation Report. Some intriguing new numbers suggest changes to healthcare delivery in the US may be influencing income.
A survey of cardiologists in Spain reveals that only three out of four cardiologists are routinely asking patients whether they smoke, and the majority admit they seldom use tools and medications to help their patients quit.
Seemingly at odds with a recent report implicating L-carnitine as a possible villain in heart disease, a report points to a more heroic potential role in acute therapy and perhaps secondary prevention.
The Rapid Activity of Platelet Inhibitor Drugs Study showed that four hours is needed to achieve effective platelet inhibition in most patients, with just 50% of treated patients having effective platelet inhibition two hours after the loading dose.
TACT, a positive, if perplexing, study, suggested that chelation therapy may modestly improve clinical outcomes in patients after an acute MI. Over a four-year follow-up, those who followed an arduous regimen involving up to 40 separate three-hour infusions of a standard chelation-therapy solution of multiple ingredients, compared with a placebo, showed an 18% drop in the trial's primary end point.
The drugmaker, Genzyme Europe, had asked for a reexamination of the EMA's Committee for Medicinal Products for Human Use December 2012 decision not to recommend approval. But once again, the recommendation was "no," despite a recent FDA decision to approve the drug.
In a move that runs counter to recent actions by the US FDA, the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended extending the indication for rivaroxaban to include prevention of atherothrombotic events in adult patients with acute coronary syndromes.
Researchers estimate that, on average, people throughout the world consume about twice as much salt as guidelines recommend, and this excess salt intake contributes to millions of hypertension-related deaths from CVD.
The use of high-dose oral vitamin therapy failed to reduce the risk of cardiovascular events in the Trial to Assess Chelation Therapy, a 2x2 factorial-design, randomized, double-blind trial that previously showed chelation therapy modestly improved clinical outcomes in patients after an acute MI.
A new study is challenging common perceptions about survival rates in patients who suffer an in-hospital cardiac arrest, underscoring the need for concerted resuscitation efforts, respecting patients' wishes, even in the elderly.
Family members who were invited to stay and witness cardiac-resuscitation efforts on a loved one who had a cardiac arrest in the home coped better later on, and their presence did not impede care delivery, in a large study.
Drs Ohman and Wallentin compare and contrast the data for P2Y12 inhibition in medically managed ACS patients. You can also DISCUSS this topic with Dr. Ohman, who will address your questions and comments on Medscape Discuss.